SCHEMBL20101356

SCHEMBL20101356

COP(=O)(OC)OC[C@H]1OCCC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27396948 0.92
SCHEMBL20386572 0.83
SCHEMBL20808560 0.83 FBP1 (0.33)
SCHEMBL25797616 0.82
SCHEMBL22112164 0.81 FBP1 (0.47)
SCHEMBL24145917 0.78 FBP1 (0.33)
SCHEMBL10034881 0.75
SCHEMBL24497709 0.73 EPHX1 (0.30)
SCHEMBL22223541 0.73 FBP1 (0.30)
SCHEMBL18874536 0.73 FBP1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3736334-A1 RNAI COMPOSITIONS TO TREAT APOC3-RELATED DISEASES Arrowhead Pharmaceuticals, Inc. (US) 2020-11-11 EP disclosed
EP-3052107-B1 ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS NOVARTIS AG (CH) 2018-05-02 EP disclosed